Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
07/07/2010 | CN101768215A House lizard glycopeptide, method for preparing same and medicinal application thereof |
07/07/2010 | CN101766810A Medical preparation containing recombinant human granulocytecolony stimulating factor |
07/07/2010 | CN101260397B Application of immobilized proteinase in preparing cream protein peptide |
07/06/2010 | US7750204 Methods for producing antibody |
07/06/2010 | US7750138 consisting of different fragments of the VEGF receptors FLT-1 and KDR and human immunoglobulin Fc; treatment of angiogenesis-related diseases including tumor, diabetic retinopathies, arthritis, anemia and endometrial hyperplasia; vectors; host cell |
07/06/2010 | US7750135 Molecular design of thermostable alcohol dehydrogenase for synthesis for chiral aromatic alcohols |
07/06/2010 | US7750126 Antibodies that bind to a member of the IL-6/G-CSF/MGF family |
07/06/2010 | US7750125 C35 tumor antigen specific monoclonal for use in diagnosis, prevention and treatment of cell proliferative disorders |
07/06/2010 | US7750124 Delta-like 4 receptor specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders |
07/06/2010 | US7750123 Immunoglobulin for treatment and prevention of severe acute respiratory syndrome and/or coronavirus related disorders |
07/06/2010 | US7750121 A recombinant human telomerase reverse transcriptase (hTRT) protein; drug screening for antiproliferative agents that inhibit hTRT activity; cancer diagnosis and prognosis; anticarcinogenic agents |
07/06/2010 | US7749758 Human and mammalian stem cell-derived neuron survival factors |
07/06/2010 | US7749753 modulation of transport proteins in biological cells; genetic engineering; antibodies |
07/06/2010 | US7749745 Herpes simplex virus comprising a mutation within the BstEII-EcoNI fragment of the BamHI x fragment of said virus; cancer vaccine |
07/06/2010 | US7749742 Method for producing tripeptides and/or peptides longer than tripeptides |
07/06/2010 | US7749735 Interferon receptor variant for treatment and prevention of cell proliferative, autoimmune and viral diseases; prolonged activation of interferon beta |
07/06/2010 | US7749733 Expression vector for identifying promoter region of genes; gene expression modulators |
07/06/2010 | US7749732 Method for preparing active nanoarchaeum equitans DNA polymerase and the active DNA polymerase prepared by the method |
07/06/2010 | US7749731 Using acid lysis to release translation products from cells |
07/06/2010 | US7749719 bioassay to detect diagnosis of skin cancer; isolated host cell transfected with the recombinant expression vector encoding an immunogenic protein; immunogen or vaccine for cancer prevention and treatment; immunotherapy |
07/06/2010 | US7749718 Method for raising or isolating an antibody to DCRS5 |
07/06/2010 | US7749518 Viral protein for use in devloping vaccine for treatment and preventon of infection, vision, arthritic and respiratory system disorders |
07/06/2010 | US7749514 Activatable clostridial toxins |
07/06/2010 | US7749506 Envelope protein for use as immunization tool in treatment and prevention of viral disease in crustaceans |
07/06/2010 | US7749504 Anti-TAT188 antibodies |
07/06/2010 | US7749502 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with Porphyromonas gingivalis |
07/06/2010 | US7749500 Antibodies to IL-17 polypeptides and therapeutic uses thereof |
07/06/2010 | US7749499 Immunoglobulin for use in diagnosis, prevention and treatment of neisserial infection; immunootherapeutics |
07/06/2010 | CA2373491C Method of detecting interacting proteins |
07/06/2010 | CA2363537C Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods |
07/06/2010 | CA2264509C Novel monoclonal antibody recognizing cell surface antigen cd14 |
07/06/2010 | CA2209360C Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen |
07/06/2010 | CA2162729C Cloning and recombinant production of crf (corticotropin releasing factor) receptor(s) |
07/06/2010 | CA2123049C Pharmaceutical containing the p40 subunit of interleukin 12 |
07/01/2010 | WO2010075194A1 Prokaryotic expression of soluble, active dkk |
07/01/2010 | WO2010074821A1 Acidothermus celluloyticus xylanase |
07/01/2010 | WO2010074266A1 Anti-cd4 antibody |
07/01/2010 | WO2010074218A1 Anti-human midkine antibody |
07/01/2010 | WO2010074192A1 Diagnosis and treatment of cancer using anti-lgr7 antibody |
07/01/2010 | WO2010074081A1 Protein substance having triple helix structure and manufacturing method therefor |
07/01/2010 | WO2010074080A1 Expression vector for producing protein derived from foreign gene in large quantity using animal cells, and use thereof |
07/01/2010 | WO2010074049A1 Anti-hs6st2 antibody and use thereof |
07/01/2010 | WO2010073694A1 Diagnosis of treatment of cancer using anti-tm4sf20 antibody |
07/01/2010 | WO2010073531A1 Muscle-building agent |
07/01/2010 | WO2010054156A3 Vaccines targeting cellular death receptors |
07/01/2010 | US20100169992 Fgfr4 antibodies |
07/01/2010 | US20100168398 Method, computing routine, device for predicting properties of MHC/peptide complexes, and data and peptides produced therefrom. |
07/01/2010 | US20100168396 Novel Branchiostoma Derived Fluorescent Proteins |
07/01/2010 | US20100168392 Expression of full length igg and secretion into the culture medium of prokaryotic cells |
07/01/2010 | US20100168389 Process for producing extract for cell-free protein synthesis and cell extract produced thereby |
07/01/2010 | US20100168380 Process for synthesizing cyclic peptide compound |
07/01/2010 | US20100168214 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer |
07/01/2010 | US20100168213 Protein-coding RNA to correct mitochondrial dysfunction |
07/01/2010 | US20100168028 Compositions and methods of using crmp-1 and its fragments for treating cancer |
07/01/2010 | US20100168027 Bpc-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells |
07/01/2010 | US20100168021 Urocortin proteins and uses thereof |
07/01/2010 | US20100168020 Stabilized receptor polypeptides and uses thereof |
07/01/2010 | US20100168015 Peptides with capacity for binding with interleukine 10 (il-10) |
07/01/2010 | US20100167957 Methods for producing active scfv antibodies and libraries therefor |
07/01/2010 | US20100167393 Modified human thymic stromal lymphopoietin |
07/01/2010 | US20100167348 Peptide capable of binding to immunoglobulin |
07/01/2010 | US20100167347 used to incorporate a selected amino acid in a specific position in a growing polypeptide chain (during nucleic acid translation) in response to a selector codon that is recognized by the tRNA |
07/01/2010 | US20100167346 Method of producing heterogeneous protein |
07/01/2010 | US20100167345 Halohydrin dehalogenases and related polynucleotides |
07/01/2010 | US20100167344 Novel sialidases |
07/01/2010 | US20100167343 Oviduct specific expression promoter and recombinant expression vector comprising the same |
07/01/2010 | US20100167342 Method of producing biologically active polypeptide having insulinotropic activity |
07/01/2010 | US20100167341 Novel protein expression system |
07/01/2010 | US20100167340 Method to produce a receptor chip using biotinylated protein |
07/01/2010 | US20100167298 PURO-DHFR Quadrifunctional Marker and its use in Protein Production |
07/01/2010 | US20100167292 High fidelity polymerases and uses thereof |
07/01/2010 | US20100166824 Extracellular matrix compositions |
07/01/2010 | US20100166799 Adenoviral vectors and methods and uses related thereto |
07/01/2010 | US20100166792 Antigenic Polypeptides |
07/01/2010 | US20100166786 A mycobacterium tuberculosis fusion protein and uses thereof |
07/01/2010 | US20100166785 lipopeptide or lipoprotein that is not only highly immunogenic itself but also can enhance the immunogenicity of other antigens; vaccine |
07/01/2010 | US20100166772 ANTIGEN-BINDING PROTEINS TARGETING S. AUREUS ORF0657n |
07/01/2010 | US20100166769 High-yield Transgenic Mammalian Expression System for Generating Virus-like Particles |
07/01/2010 | US20100166768 High Affinity Human Antibodies to PCSK9 |
07/01/2010 | US20100166767 Engineered anti-il-23r antibodies |
07/01/2010 | US20100166766 Engineered anti-tslp antibody |
07/01/2010 | US20100166763 Method for determining the immunogenicity of an antigen |
07/01/2010 | US20100166761 Compositions and methods for the treatment of immune related diseases |
07/01/2010 | US20100166758 Novel antibody molecules and nucleic acids |
07/01/2010 | US20100166753 Humanized monoclonal antibodies that protect against shiga toxin induced disease |
07/01/2010 | US20100166749 Polypeptide variants with altered effector function |
07/01/2010 | US20100166748 C5 Antigens and Uses Thereof |
07/01/2010 | US20100166733 Mcp-1 splice variants and methods of using same |
07/01/2010 | US20100166732 Small streptococcus pyogenes antigens and their use |
07/01/2010 | US20100166725 Human Cystathionine beta-Synthase Variants and Methods of Production Thereof |
07/01/2010 | US20100166658 Monkey homolog of human oncostatin m |
07/01/2010 | CA2748990A1 Diagnosis and treatment of cancer using anti-lgr7 antibody |
07/01/2010 | CA2748135A1 Heterologous biomass degrading enzyme expression in thermoanaerobacterium saccharolyticum |
07/01/2010 | CA2748015A1 Protein substance having triple helix structure and manufacturing method therefor |
07/01/2010 | CA2748011A1 Expression vector for producing protein derived from foreign gene in large quantity using animal cells, and use thereof |
07/01/2010 | CA2747827A1 System for production of ethanol and co-products |
07/01/2010 | CA2746929A1 Acidothermus celluloyticus xylanase |
06/30/2010 | EP2202315A1 Modified vaccinia ankara virus variant |
06/30/2010 | EP2202308A2 Methods and compositions for polypeptide engineering |
06/30/2010 | EP2202307A1 Method for production of antibody |